Why Big Pharma is chasing the industry’s most-powerful supercomputer

Bristol Myers Squibb is the latest major drugmaker to tap Nvidia for more computing power, betting that larger models and AI agents can speed drug discovery.

Raccontata dabiopharmadive.com